Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $883.74M | $925.95M | -4.56% |
Gross Profit | $525.88M | $548.13M | -4.06% |
Net Income | $163.59M | $177.51M | -7.84% |
EPS (Basic) | $7.84 | $8.28 | -5.31% |
EPS (Diluted) | $7.81 | $8.24 | -5.22% |
R&D Expense | $46.35M | $46.41M | -0.15% |
SG&A Expense | $242.8M | $234.39M | +3.59% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.23B | $3.28B | -1.48% |
Current Assets | $1.16B | $1.21B | -3.82% |
Total Liabilities | $3.42B | $3.44B | -0.73% |
Current Liabilities | $1.15B | $1.13B | +1.57% |
Stockholders' Equity | $-181.98M | $-158.72M | -14.66% |
Long-Term Debt | $1.89B | $1.9B | -0.65% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $194.45M | $189.99M | +2.35% |
Investing Cash Flow | $-6.91M | $-8.94M | +22.70% |
Financing Cash Flow | $-184.15M | $-179.09M | -2.83% |
Share Buybacks | $218.75M | $212.5M | +2.94% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 59.5% | 59.2% | +0.31% |
Net Margin | 18.5% | — | — |
ROE | -89.9% | — | — |
ROA | 5.1% | — | — |
Current Ratio | $1.013 | — | — |
Debt to Equity | $-18.775 | — | — |
Other companies in Life Sciences Tools & Services